EPISODE · Jun 25, 2026 · 5 MIN
今天3分钟我们来聊聊NK细胞逆转晚期肺癌新突破
from 源于细胞BioInsid的个人播客
晚期肺癌患者化疗、免疫治疗失败后，通过6次自体NK细胞输注联合吉西他滨和贝伐珠单抗，原发肿瘤显著缩小，淋巴结消失，症状缓解且无副作用，为晚期肺癌治疗打开新通路。参考文献：Autologous NK cell combined with gemcitabine and bevacizumab in advanced NSCLC: a case report. Respiratory Medicine Case Reports前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊NK细胞逆转晚期肺癌新突破
0:00
5:07
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 5 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on June 25, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!